Idelvion Approved for Hemophilia B

MONDAY, March 7, 2016 — Idelvion has been approved by the U.S. Food and Drug Administration to replace a deficient blood clotting factor among people with hemophilia B.
The product — which has the generic name of “coagulation Factor IX, albumin…
Source: Topamax